INTERCEPT PHARMACEUTICALS, INC.·4

Jan 3, 4:02 PM ET

Richardson Linda M 4

4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Jan 3, 2023

Insider Transaction Report

Form 4
Period: 2022-12-31
Richardson Linda M
EVP & Chief Commercial Officer
Transactions
  • Tax Payment

    Common Stock

    2022-12-31$12.37/sh1,600$19,79231,477 total
Footnotes (1)
  • [F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock unit awards previously granted to the reporting person.

Documents

1 file
  • 4
    tm231319-5_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT